Treatment Strategies and Risk Stratification in Acute Coronary Syndrome: How Do We Identify Patients Who Would Benefit From Early Invasive Treatment?

被引：2
作者：
de Winter, Robbert J. [1 ]
机构：
[1] Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Paises Bajos, Netherlands
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2010年 / 63卷 / 08期
关键词：
MANAGEMENT; METAANALYSIS; ROUTINE;
D O I：
10.1016/S0300-8932(10)70199-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：888 / 889
页数：2
相关论文
共 50 条
  • [21] Preferences of Patients With Chronic Kidney Disease for Invasive Versus Conservative Treatment of Acute Coronary Syndrome: A Discrete Choice Experiment
    Wilson, Todd A.
    Hazlewood, Glen S.
    Sajobi, Tolulope T.
    Wilton, Stephen B.
    Pearson, Winnie E.
    Connolly, Carol
    Javaheri, Pantea A.
    Finlay, Juli L.
    Levin, Adeera
    Graham, Michelle M.
    Tonelli, Marcello
    James, Matthew T.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (06):
  • [22] Early Surgery and Screw-Only Osteosyntheses in Minimally Invasive Treatment of Calcaneal Fractures-Risk or Benefit for Our Patients?
    Rodemund, Christian
    Katzensteiner, Moritz
    Vogel, Maximilian
    Mattiassich, Georg
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [23] Treatment practices and lipid profile of patients with acute coronary syndrome: results from a tertiary care hospital
    Farmakis, Ioannis
    Zafeiropoulos, Stefanos
    Kartas, Anastasios
    Boulmpou, Aristi
    Nevras, Vasileios
    Papadimitriou, Ioannis
    Tampaki, Athina
    Vlachou, Anastasia
    Markidis, Eleftherios
    Koutsakis, Athanasios
    Ziakas, Antonios
    Karvounis, Haralambos
    Giannakoulas, George
    ACTA CARDIOLOGICA, 2020, 75 (06) : 527 - 534
  • [24] Higher Baseline LDL-C Levels Amplify the Short-Term Benefit of Early Intensive Statin Treatment in Acute Coronary Syndrome
    Dohi, Tomotaka
    Miyauchi, Katsumi
    Okazaki, Shinya
    Yokoyama, Takayuki
    Yanagisawa, Naotake
    Tamura, Hiroshi
    Kojima, Takahiko
    Yokoyama, Ken
    Kurata, Takeshi
    Daida, Hiroyuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011, 18 (01) : 42 - 48
  • [25] Arterial Access-Site-Related Outcomes of Patients Undergoing Invasive Coronary Procedures for Acute Coronary Syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non-ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy)
    Sciahbasi, Alessandro
    Pristipino, Christian
    Ambrosio, Giuseppe
    Sperduti, Isabella
    Scabbia, Enrico Vittorio
    Greco, Cesare
    Ricci, Roberto
    Ferraiolo, Giuseppe
    Di Clemente, Domenico
    Giombolini, Claudio
    Lioy, Ernesto
    Tubaro, Marco
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (06) : 796 - 800
  • [26] Antitbrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events
    Zhang Li-jie
    Chen Yun-dai
    Song Xian-tao
    Zhao Fu-hai
    Lue Shu-zheng
    CHINESE MEDICAL JOURNAL, 2009, 122 (05) : 502 - 508
  • [27] Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio
    Renaud, Stephane
    Falcoz, Pierre-Emmanuel
    Olland, Anne
    Reeb, Jeremie
    Santelmo, Nicola
    Massard, Gilbert
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2015, 20 (02) : 222 - 227
  • [28] 5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial A Randomized Comparison of an Early Invasive Versus Selective Invasive Management in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
    Damman, Peter
    Hirsch, Alexander
    Windhausen, Fons
    Tijssen, Jan G. P.
    de Winter, Robbert J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (09) : 858 - 864
  • [29] Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: Results from the antiplatelet treatment observational registries (APTOR)
    Zeymer, Uwe
    Berkenboom, Guy
    Coufal, Zdenek
    Belger, Mark
    Sartral, Magali
    Norrbacka, Kirsi
    Bakhai, Ameet
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 170 (02) : 239 - 245
  • [30] Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)
    Sharma, Abhinav
    Sun, Jie-Lena
    Lokhnygina, Yuliya
    Roe, Matthew T.
    Ahmad, Tariq
    Desai, Nihar R.
    Blazing, Michael A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (08) : 1193 - 1201
12345